Growth, body composition, and endocrine issues in Williams syndrome
- PMID: 33165016
- PMCID: PMC8130831
- DOI: 10.1097/MED.0000000000000588
Growth, body composition, and endocrine issues in Williams syndrome
Abstract
Purpose of review: Williams syndrome is a multisystem disorder caused by a microdeletion on chromosome 7q. Throughout infancy, childhood, and adulthood, abnormalities in body composition and in multiple endocrine axes may arise for individuals with Williams syndrome. This review describes the current literature regarding growth, body composition, and endocrine issues in Williams syndrome with recommendations for surveillance and management by the endocrinologist, geneticist, or primary care physician.
Recent findings: In addition to known abnormalities in stature, calcium metabolism, and thyroid function, individuals with Williams syndrome are increasingly recognized to have low bone mineral density, increased body fat, and decreased muscle mass. Furthermore, recent literature identifies a high prevalence of diabetes and obesity starting in adolescence, and, less commonly, a lipedema phenotype in both male and female individuals. Understanding of the mechanisms by which haploinsufficiency of genes in the Williams syndrome-deleted region contributes to the multisystem phenotype of Williams syndrome continues to evolve.
Summary: Multiple abnormalities in growth, body composition, and endocrine axes may manifest in individuals with Williams syndrome. Individuals with Williams syndrome should have routine surveillance for these issues in either the primary care setting or by an endocrinologist or geneticist.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Figures

References
-
- Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239–52. - PubMed
-
- Morris CA, Braddock SR, Council On G. Health Care Supervision for Children With Williams Syndrome. Pediatrics. 2020;145(2). - PubMed
-
These comprehensive guidelines for care of children and adults with WS update the previous 2001 guidelines and offer providers concise recommendations on surveillance and management, including for the multiple endocrine abnormalities associated with WS.
-
- Ewart AK, Morris CA, Atkinson D, Jin W, Sternes K, Spallone P, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. 1993;5(1):11–6. - PubMed
-
- Levy-Shraga Y, Gothelf D, Pinchevski-Kadir S, Katz U, Modan-Moses D. Endocrine manifestations in children with Williams-Beuren syndrome. Acta Paediatr. 2018;107(4):678–84. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials